Awarded - 43885- Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colorectal cancer (Cetuximab) and/or (Panitumumab)

World Biggest Tenders Source

This tender with title Awarded - 43885- Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colorectal cancer (Cetuximab) and/or (Panitumumab) -- Contract Value: 1 319 749,20 EUR has been published on Bidding Source portal dated 29 Jan 2026 for the country of Lithuania. It has been categorized on Antineoplastic agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 1 319 749,20 EUR

General Information

Lithuania

Tender Title :

Awarded - 43885- Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colorectal cancer (Cetuximab) and/or (Panitumumab)
Contract Value: 1 319 749,20 EUR

Tender Type :

Contract Award

Reference No. :

43885

Country :

Lithuania

Publish Date :

29 Jan 2026

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

775598-Awarded - Lithuania – Antineoplastic agents – Y90 Microspheres for radioembolization of liver tumors -- Contract Value: 273 000,00 EUR Lithuania 677578- Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colorectal cancer (Cetuximab) and/or (Panitumumab) Lithuania 639597-Awarded - Lithuania – Antineoplastic agents – Medicinal product Vandetanib -- Contract Value: 17 737,50 EUR Lithuania 574771-Awarded - Lithuania – Antineoplastic agents – Medicinal product Vandetanib -- Contract Value: 21 285,00 EUR Lithuania 530468- Lithuania – Antineoplastic agents – Y90 Microspheres for radioembolization of liver tumors Lithuania 520604-Awarded - Lithuania – Antineoplastic agents – Y90 Microspheres for radioembolization of liver tumors Lithuania Monoclonal antibodies for metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) Lithuania Lithuania - Monoclonal antibodies for first- and second-line treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) -- Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui I bei II eilei gydyti (Cetuximab ir (ar) Panitumumab) Lithuania Monokloniniai antikūnai Bevacizumab -- Antineoplastic agents Lithuania Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui I bei II eilei gydyti (Cetuximab ir (ar) Panitumumab) -- Antineoplastic agents Lithuania

Awarded - 43885- Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colorectal cancer (Cetuximab) and/or (Panitumumab)

Contract Value: 1 319 749,20 EUR

General Information

Lithuania

Similar Tenders

Antineoplastic agents Tenders

Lithuania Tenders

Europe Tenders

Tenders

info@biddingsource.com